Navigation Links
ARVO launches new journal on translational research
Date:1/13/2012

Rockville, MD The Association for Research in Vision and Ophthalmology (ARVO) launched its third journal, Translational Vision Science & Technology (TVST), with an open call for manuscript submissions this month. TVST is an online only, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care.

The new journal will publish manuscripts in English language by scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery, bringing together research that, until now, often has been published in journals other than those directly related to ophthalmology.

"TVST's focus on translational research is unique, as is the attempt to bring innovators and facilitators together through a periodical that has extremely high standards," said TVST's editor-in-chief, Marco Zarbin, MD, PhD, FARVO. "Our goal is to create a venue in which these innovations can be subject to rigorous peer review and, having been strengthened by that process, make their way into the public domain and directly to the attention of an appropriate audience of fellow innovators and potential scientific and business partners."

Zarbin is the chair of the Institute of Ophthalmology and Visual Science, New Jersey Medical School and chief of ophthalmology at University Hospital in Newark, N.J. He is a professor of ophthalmology and neuroscience and holds the Alfonse A. Cinotti, MD/Lions Eye Research Chair in the Department of Ophthalmology. In addition to his current role with TVST, Zarbin previously served as an associate editor of ARVO's Investigative Ophthalmology and Visual Science (IOVS) journal.

Appointed by ARVO Board of Trustees, Zarbin is joined by a team of highly-qualified associate editors and editorial board members from across the globe in publishing the new journal, which will cover a broad spectrum of work, including:

  • Applications of stem cell technology for regenerative medicine
  • Development of new animal models of human diseases
  • Tissue bioengineering
  • Chemical engineering to improve virus-based gene delivery
  • Nanotechnology for drug delivery
  • Design and synthesis of artificial extracellular matrices
  • Development of a true microsurgical operating environment
  • Refining data analysis algorithms to improve in vivo imaging technology
  • Results of Phase 1 clinical trials
  • Reverse translational ("bench to bedside") research

"TVST will be an excellent complement to ARVO's other journals IOVS and Journal of Vision by providing thorough review yet timely dissemination of cutting-edge research aimed at novel treatment of vision-threatening diseases," said ARVO President Jeffrey H. Boatright, PhD, FARVO.

The inaugural issue of TVST is planned for release this spring. For information on the manuscript submission process, visit www.arvo.org/tvstjournal.


'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related biology news :

1. Malaysian Prime Minister launches company for supply of biomass from oil palm
2. Allen Institute for Brain Science launches new atlas, adds new data and tools to others
3. RV Polarstern launches 28th Antarctic season
4. Scripps launches whole genome sequencing study to find root causes of idiopathic diseases
5. American Life Sciences Innovation Council Launches
6. FDA grant launches Atlanta Pediatric Device Consortium
7. NIH launches research program to explore health effects from climate change
8. MedNet Solutions Launches the iMedNet CRO Partner Program
9. MSU professor launches new field of water research, nets $2.2 million NSF grant
10. Elsevier launches Current Opinion in Virology
11. SIB launches next generation ExPASy, an entry portal to indispensable bioinformatics resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 2017  GCE Solutions, a global clinical research organization (CRO), announces ... solution on October 4, 2017. Shadow is designed to assist medical ... policy 0070 of the European Medicines Agency (EMA) in meeting the ... ... ...
(Date:7/20/2017)... Delta (NYSE: DAL ) customers now can use ... Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington ... Delta,s biometric boarding pass experience that ... integrated into the boarding process to allow eligible Delta SkyMiles Members who ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... ... a four-tiered line of medical marijuana products targeting the needs of consumers who ... packaging of Kindred takes place in Phoenix, Arizona. , As operators of two ...
Breaking Biology Technology: